148 related articles for article (PubMed ID: 2847291)
1. Treatment of cytomegalovirus pneumonia.
Crumpacker C; Marlowe S; Zhang JL; Abrams S; Watkins P
Rev Infect Dis; 1988; 10 Suppl 3():S538-46. PubMed ID: 2847291
[TBL] [Abstract][Full Text] [Related]
2. Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients.
Winston DJ; Ho WG; Bartoni K; Holland GN; Mitsuyasu RT; Gale RP; Busuttil RW; Champlin RE
Rev Infect Dis; 1988; 10 Suppl 3():S547-53. PubMed ID: 2847292
[TBL] [Abstract][Full Text] [Related]
3. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts.
Erice A; Jordan MC; Chace BA; Fletcher C; Chinnock BJ; Balfour HH
JAMA; 1987 Jun; 257(22):3082-7. PubMed ID: 3035246
[TBL] [Abstract][Full Text] [Related]
4. Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipients.
Keay S; Petersen E; Icenogle T; Zeluff BJ; Samo T; Busch D; Newman CL; Buhles WC; Merigan TC
Rev Infect Dis; 1988; 10 Suppl 3():S563-72. PubMed ID: 2847294
[TBL] [Abstract][Full Text] [Related]
5. Treatment of cytomegalovirus pneumonitis with ganciclovir in renal transplantation.
Stoffel M; Pirson Y; Squifflet JP; Lamy M; Gianello P; Alexandre GP
Transpl Int; 1988 Dec; 1(4):181-5. PubMed ID: 2855305
[TBL] [Abstract][Full Text] [Related]
6. Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir.
Verdonck LF; de Gast GC; Dekker AW; de Weger RA; Schuurman HJ; Rozenberg-Arska M
Bone Marrow Transplant; 1989 Mar; 4(2):187-9. PubMed ID: 2539877
[TBL] [Abstract][Full Text] [Related]
7. Ganciclovir and hyperimmunoglobulin for treating cytomegalovirus infection in bone marrow transplant recipients.
Aulitzky WE; Tilg H; Niederwieser D; Hackl M; Meister B; Huber C
J Infect Dis; 1988 Aug; 158(2):488-9. PubMed ID: 2841384
[No Abstract] [Full Text] [Related]
8. Ganciclovir therapy for cytomegalovirus disease associated with renal transplants.
Snydman DR
Rev Infect Dis; 1988; 10 Suppl 3():S554-62. PubMed ID: 2847293
[TBL] [Abstract][Full Text] [Related]
9. Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy.
Turgeon N; Fishman JA; Basgoz N; Tolkoff-Rubin NE; Doran M; Cosimi AB; Rubin RH
Transplantation; 1998 Dec; 66(12):1780-6. PubMed ID: 9884276
[TBL] [Abstract][Full Text] [Related]
10. Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients.
Buhles WC; Mastre BJ; Tinker AJ; Strand V; Koretz SH
Rev Infect Dis; 1988; 10 Suppl 3():S495-506. PubMed ID: 2847286
[TBL] [Abstract][Full Text] [Related]
11. DHPG (Gancyclovir) improves survival in CMV pneumonia.
Mai M; Nery J; Sutker W; Husberg B; Klintmalm G; Gonwa T
Transplant Proc; 1989 Feb; 21(1 Pt 2):2263-5. PubMed ID: 2540565
[No Abstract] [Full Text] [Related]
12. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants.
Reed EC; Bowden RA; Dandliker PS; Lilleby KE; Meyers JD
Ann Intern Med; 1988 Nov; 109(10):783-8. PubMed ID: 2847610
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapy.
Enright H; Haake R; Weisdorf D; Ramsay N; McGlave P; Kersey J; Thomas W; McKenzie D; Miller W
Transplantation; 1993 Jun; 55(6):1339-46. PubMed ID: 8390734
[TBL] [Abstract][Full Text] [Related]
14. Treatment of cytomegalovirus pneumonia in heart transplant recipients with 9(1,3-dihydroxy-2-proproxymethyl)-guanine (DHPG).
Watson FS; O'Connell JB; Amber IJ; Renlund DG; Classen D; Johnston JM; Smith CB; Bristow MR
J Heart Transplant; 1988; 7(2):102-5. PubMed ID: 2835468
[TBL] [Abstract][Full Text] [Related]
15. Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia.
Shepp DH; Dandliker PS; de Miranda P; Burnette TC; Cederberg DM; Kirk LE; Meyers JD
Ann Intern Med; 1985 Sep; 103(3):368-73. PubMed ID: 2992333
[TBL] [Abstract][Full Text] [Related]
16. Treatment of cytomegalovirus pneumonia with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine and high-dose corticosteroids.
Reed EC; Dandliker PS; Meyers JD
Ann Intern Med; 1986 Aug; 105(2):214-5. PubMed ID: 3014941
[No Abstract] [Full Text] [Related]
17. A risk-adapted approach with a short course of ganciclovir to prevent cytomegalovirus (CMV) pneumonia in CMV-seropositive recipients of allogeneic bone marrow transplants.
Verdonck LF; Dekker AW; Rozenberg-Arska M; van den Hoek MR
Clin Infect Dis; 1997 May; 24(5):901-7. PubMed ID: 9142790
[TBL] [Abstract][Full Text] [Related]
18. Ganciclovir sensitivity of cytomegalovirus at diagnosis and during treatment of cytomegalovirus pneumonia in marrow transplant recipients.
Slavin MA; Bindra RR; Gleaves CA; Pettinger MB; Bowden RA
Antimicrob Agents Chemother; 1993 Jun; 37(6):1360-3. PubMed ID: 8392311
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin.
Emanuel D; Cunningham I; Jules-Elysee K; Brochstein JA; Kernan NA; Laver J; Stover D; White DA; Fels A; Polsky B
Ann Intern Med; 1988 Nov; 109(10):777-82. PubMed ID: 2847609
[TBL] [Abstract][Full Text] [Related]
20. Treatment of cytomegalovirus pneumonitis after bone marrow transplantation with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine.
Selby P; Powles RL; Jameson B; Stolle K; Tryhorn Y; Stern H
Lancet; 1986 Jun; 1(8494):1377-8. PubMed ID: 2872484
[No Abstract] [Full Text] [Related]
[Next] [New Search]
